NMTC - EARNINGS -
https://www.stocktitan.net/news/NMTC/neuro-one-r-reports-third-quarter-fiscal-year-2024-financial-results-faqksv1wj5jc.html

NeuroOne signs distro deal for neuroablation system, brings in more than $5M
AUGUST 5, 2024 BY SEAN WHOOLEY

FacebookXLinkedInShare
NeuroOne_Logo (1)NeuroOne Medical Technologies (Nasdaq:NMTC) announced today that it signed a distribution deal for its OneRF ablation system.

The Eden Prairie, Minnesota-based company signed a non-binding term sheet with an undisclosed global medical technology company. The partnership remains subject to the negotiation and execution of definitive documentation, due diligence and other closing conditions.

NeuroOne’s latest partnership could mirror the one it has with Zimmer Biomet for its Evo sEEG electrodes.

The company’s OneRF system picked up FDA 510(k) clearance in December 2023. Indications cover the creation of radiofrequency (RF) lesions in nervous tissue for functional neurosurgical procedures. This technology uses already-implanted sEEG electrodes to record brain activity and enable the ablation of nervous tissue. It connects to a proprietary radiofrequency (RF) generator. NeuroOne’s electrodes provide a similar function at the subsurface level of the brain compared to cortical electrodes.

NeuroOne also closed a $2.65 million private placement and added $3 million in an additional credit facility.

“Today’s financings, $3 million of which is minimally dilutive to our shareholders, puts our company in a strong position to operate our business and move forward with a potential partnership for our OneRF Ablation System, which we anticipate will close by the end of the third calendar quarter,” Dave Rosa, CEO of NeuroOne, said in a news release.

More about the NeuroOne financings
NeuroOne’s private placement consisted of an aggregate of nearly 3 million shares of common stock, plus warrants to purchase 2.2 million shares of common stock at a purchase price of 90¢ per unit. Each unit consisted of one share of common stock and a warrant to purchase 0.75 shares of common stock.

Warrants have an exercise price of $1.19 per share of common stock. They’re exercisable for a period of three years from the date of issuance. Investors in this placement included current institutional investors and insiders.

The company also secured its $3 million credit line from Growth Opportunity Funding, LLC.

NeuroOne plans to use proceeds from its offering to fund operations, working capital and general corporate purposes. That could include expanding commercialization efforts for the limited OneRF launch. It could also extend to product development for a new ablation indication and completion of the diligence process with a potential strategic partners.

Might be soon if it drops below $8.85 and opens below it

$NMTC - VERY SOLID - AWESOME PRODUCT - DO YOUR DD - EARNINGS THIS MONDAY 8/12 - LOOK FOR SOMETHING INTERESTING - VERY LOW FLOAT

Bounced off the low on 8/5 - has funding and earnings out 8/12 - Got the hospital code and has FDA approval.
Hummmmmmmmmmmmm....... Might get really interesting

This might get interesting....

? why doesn't NVAX show on the Breakout board?

Company just getting started bro..
Takes time

$BBBT Black Bird Biotech Signs Distribution Agreement with Chicago-based Distributor of Luxury Spa Products for its Grizzly Creek Naturals(TM) CBD Product Line
BBBT | 9 hours ago
FLOWER MOUND, TX / ACCESSWIRE / August 18, 2022 /Black Bird Biotech, Inc.(OTC PINK:BBBT), manufacturer and distributor of plant-based MiteXstreamTM biopesticide, announced that it has entered into a distribution agreement for its Grizzly Creek NaturalsTM CBD product line with Chicago-based Beyond Das Skin, a national distributor of luxury spa products. During its over 40 years of distribution operations, Beyond Das Skin has established a product distribution network that covers Chicago, Las Vegas, New York, Texas and the Florida East Coast.

Owner of Beyond Das Skin owner, Andreas Jungermann, said, "I am truly excited to add the Grizzly Creek NaturalsTM line to our ever-growing catalog. It fills our CBD void while providing the same high-quality, spa-level product we take pride in selling to our clients. The CBD industry is a rapidly growing market that we can, and will, make a major impact in. We look forward to distributing for Black Bird Biotech."

"We are extremely pleased that Andreas and his Beyond Das Skin team will be taking our Grizzly Creek NaturalsTM CBD products into markets across the country. Their earnest approach to getting this deal done, coupled with their sense of ‘team,' has instilled us with great confidence for our future together," said Fabian Deneault, BBBT's President. "The work on the redesign of our labels and Grizzly Creek NaturalsTM website, which will mark a return to our ‘Big Sky Montana' themes of the past, is nearing completion, and we believe this will allow our CBD products to settle nicely into their channel within the broader Beyond Das Skin product offerings."
According to an April 2022 report by Global Market Insights, the CBD market totaled $12.8 billion in 2021 and is expected to grow at a CAGR of 21.7% between 2022 and 2028. This expected growth is attributed to rising awareness of health benefits of CBD and its effectiveness in pain management and various other treatments. In addition, pet wellness is becoming a significant driver of CBD sales growth.

For news and updates, shareholders, prospective investors and prospective business partners are encouraged to follow @BBBT_Corporate on Twitter and @BlackBirdBiotech on Instagram. Also visit BBBT's corporate website, BlackBirdBiotech.com, for additional information about the company.

About Beyond Das Skin

Beyond das Skin is a family owned and operated business providing luxurious spa products for the entire family. Whether you are looking for a relaxing girl's night in, that perfect shave, or for the kid's bubble bath to be 5-star level fun, Beyond das Skin brings the Spa and Salon feel into your home. With 40 years of experience supplying amenities to spas, salons, golf courses, and athletic clubs throughout the United States, owner Andreas Jungermann has developed relationships with vendors and equipment managers to distribute in Chicago, Las Vegas, New York, Texas, and the eastern coast of Florida.

Black Bird Biotech, Inc., Thursday, August 18, 2022, Press release picture
About BBBT

Black Bird Biotech is positioned to exploit market segments with powerful, re-imagined biotech products. Its EPA-registered biopesticide, MiteXstreamTM, eradicates mites and similar pests, including spider mites (a lethal pest in cannabis, grapes, hops, coffee, strawberries and many other agricultural crops), and eliminates molds and mildews. MiteXstreamTM is a pesticide, but it is not a poison - it's a pesticide re-imagined.The MiteXstreamTM Edges: it is HONEY BEE SAFE and it can be used through the day of harvest without concern for residual "pesticide" violations, including as it pertains to state cannabis testing. MiteXstreamTM is the foundational element of the company that carries vast potential worldwide as a highly effective, safe and extremely cost-effective replacement for many traditional "poisonous" pesticides.

About BBBT

Black Bird Biotech is positioned to exploit market segments with powerful, re-imagined biotech products. Its EPA-registered biopesticide, MiteXstreamTM, eradicates mites and similar pests, including spider mites (a lethal pest in cannabis, grapes, hops, coffee, strawberries and many other agricultural crops), and eliminates molds and mildews. MiteXstreamTM is a pesticide, but it is not a poison - it's a pesticide re-imagined.The MiteXstreamTM Edges: it is HONEY BEE SAFE and it can be used through the day of harvest without concern for residual "pesticide" violations, including as it pertains to state cannabis testing. MiteXstreamTM is the foundational element of the company that carries vast potential worldwide as a highly effective, safe and extremely cost-effective replacement for many traditional "poisonous" pesticides.

Forward Looking Statements:

This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

$BBBT Black Bird Biotech Signs Distribution Agreement with Chicago-based Distributor of Luxury Spa Products for its Grizzly Creek Naturals(TM) CBD Product Line
BBBT | 9 hours ago
FLOWER MOUND, TX / ACCESSWIRE / August 18, 2022 /Black Bird Biotech, Inc.(OTC PINK:BBBT), manufacturer and distributor of plant-based MiteXstreamTM biopesticide, announced that it has entered into a distribution agreement for its Grizzly Creek NaturalsTM CBD product line with Chicago-based Beyond Das Skin, a national distributor of luxury spa products. During its over 40 years of distribution operations, Beyond Das Skin has established a product distribution network that covers Chicago, Las Vegas, New York, Texas and the Florida East Coast.

Owner of Beyond Das Skin owner, Andreas Jungermann, said, "I am truly excited to add the Grizzly Creek NaturalsTM line to our ever-growing catalog. It fills our CBD void while providing the same high-quality, spa-level product we take pride in selling to our clients. The CBD industry is a rapidly growing market that we can, and will, make a major impact in. We look forward to distributing for Black Bird Biotech."

"We are extremely pleased that Andreas and his Beyond Das Skin team will be taking our Grizzly Creek NaturalsTM CBD products into markets across the country. Their earnest approach to getting this deal done, coupled with their sense of ‘team,' has instilled us with great confidence for our future together," said Fabian Deneault, BBBT's President. "The work on the redesign of our labels and Grizzly Creek NaturalsTM website, which will mark a return to our ‘Big Sky Montana' themes of the past, is nearing completion, and we believe this will allow our CBD products to settle nicely into their channel within the broader Beyond Das Skin product offerings."
According to an April 2022 report by Global Market Insights, the CBD market totaled $12.8 billion in 2021 and is expected to grow at a CAGR of 21.7% between 2022 and 2028. This expected growth is attributed to rising awareness of health benefits of CBD and its effectiveness in pain management and various other treatments. In addition, pet wellness is becoming a significant driver of CBD sales growth.

For news and updates, shareholders, prospective investors and prospective business partners are encouraged to follow @BBBT_Corporate on Twitter and @BlackBirdBiotech on Instagram. Also visit BBBT's corporate website, BlackBirdBiotech.com, for additional information about the company.

About Beyond Das Skin

Beyond das Skin is a family owned and operated business providing luxurious spa products for the entire family. Whether you are looking for a relaxing girl's night in, that perfect shave, or for the kid's bubble bath to be 5-star level fun, Beyond das Skin brings the Spa and Salon feel into your home. With 40 years of experience supplying amenities to spas, salons, golf courses, and athletic clubs throughout the United States, owner Andreas Jungermann has developed relationships with vendors and equipment managers to distribute in Chicago, Las Vegas, New York, Texas, and the eastern coast of Florida.

Black Bird Biotech, Inc., Thursday, August 18, 2022, Press release picture
About BBBT

Black Bird Biotech is positioned to exploit market segments with powerful, re-imagined biotech products. Its EPA-registered biopesticide, MiteXstreamTM, eradicates mites and similar pests, including spider mites (a lethal pest in cannabis, grapes, hops, coffee, strawberries and many other agricultural crops), and eliminates molds and mildews. MiteXstreamTM is a pesticide, but it is not a poison - it's a pesticide re-imagined.The MiteXstreamTM Edges: it is HONEY BEE SAFE and it can be used through the day of harvest without concern for residual "pesticide" violations, including as it pertains to state cannabis testing. MiteXstreamTM is the foundational element of the company that carries vast potential worldwide as a highly effective, safe and extremely cost-effective replacement for many traditional "poisonous" pesticides.

About BBBT

Black Bird Biotech is positioned to exploit market segments with powerful, re-imagined biotech products. Its EPA-registered biopesticide, MiteXstreamTM, eradicates mites and similar pests, including spider mites (a lethal pest in cannabis, grapes, hops, coffee, strawberries and many other agricultural crops), and eliminates molds and mildews. MiteXstreamTM is a pesticide, but it is not a poison - it's a pesticide re-imagined.The MiteXstreamTM Edges: it is HONEY BEE SAFE and it can be used through the day of harvest without concern for residual "pesticide" violations, including as it pertains to state cannabis testing. MiteXstreamTM is the foundational element of the company that carries vast potential worldwide as a highly effective, safe and extremely cost-effective replacement for many traditional "poisonous" pesticides.

Forward Looking Statements:

This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Trading is getting very interesting here

Very interesting press release

Here ya go.

$BBBT Black Bird Biotech Management Affirms Long-Term Commitment, Exchanges One-Third, over 120 Million, of Outstanding Common Shares for Preferred Shares
Black Bird Biotech, Inc.
Mon, August 15, 2022 at 8:00 AM·4 min read
FLOWER MOUND, TX / ACCESSWIRE / August 15, 2022 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer and distributor of plant-based MiteXstreamTM biopesticide, announced that the members of its Board of Directors have agreed to exchange a total of nearly 124 million shares, or approximately 36%, of the Company's outstanding common stock for shares of a new Series A Preferred Stock. All of the transactions are expected to be completed by August 19, 2022, with two of the transactions, representing approximately 99 million shares of common stock, expected to be completed today, August 15, 2022.

In announcing these actions, the Company's President, Fabian Deneault, stated, "We've invested four years into our MiteXstreamTM Mission and we will gladly invest that again, and then some, if that is what it takes to establish MiteXstreamTM as the globally-recognized game-changing biopesticide that we know it is. Our actions reaffirm our team's commitment to that Mission, on the one hand, and, on the other, our commitment to taking decisive actions we believe will minimize dilution to our shareholders over the long term, especially as the MiteXstreamTM message is gaining traction. The dynamic quality of MiteXstreamTM demands these commitments."

Bill LoBell, the Company's Sales Executive VP, added, "To Fabian's point, two recent sales of MiteXstreamTM are illustrative of the ‘ah-hah' moments that are happening. About a month ago, a customer in a smaller Oklahoma town purchased a gallon of MiteXstreamTM through our online store. Accounting for shipping time, this customer purchased three more gallons last week, after just two-and-a-half or three weeks. Clearly, MiteXstreamTM did the job as advertised. And, we remain excited to show MiteXstreamTM at the Cannabis Conference 2022 in Las Vegas later this month."

The holders of the Company's Series A Preferred Stock possess, as a class, voting control of the Company and have the right to convert their Series A Preferred Stock back into shares of common stock at any time. More information about the Series A Preferred Stock and their issuance is available on the Company's SEC EDGAR page.

For news and updates, shareholders, prospective investors and prospective business partners are encouraged to follow @BBBT_Corporate on Twitter and @BlackBirdBiotech on Instagram. Also visit BBBT's corporate website, BlackBirdBiotech.com, for additional information about the company.

BBBT Black Bird Biotech Opens Grizzly Creek Naturals CBD Affiliate Sales Sign-up Portal Ahead of Sales Program Launch
Black Bird Biotech, Inc.
Tue, August 9, 2022 at 8:55 AM·3 min read
FLOWER MOUND, TX / ACCESSWIRE / August 9, 2022 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer and distributor of plant-based MiteXstreamTM biopesticide, announced the opening of a Sign-up Portal for its Affiliate Sales Program for its Grizzly Creek NaturalsTM CBD product line. Future Grizzly Creek NaturalsTM Affiliate Sales Reps can sign up at GrizzlyCreekAffiliates.com. The Company has scheduled the program launch for September 7, 2022.

"We ensure that our CBD products are of the highest quality and have been successful in maintaining a low-cost production capability, which has become extremely important in this period of significant inflation that has hit the supply chain especially hard," said Fabian Deneault, BBBT's President. "Our affiliate sales program is designed to minimize the impact of inflationary pressures on our end and, with a 20% sales commission structure, to maximize the reward for our Affiliates. As a guy that took on extra work to provide for his young family, I know that supplemental income from commissions that can offset the recent sudden increases in food and gas prices will be a welcomed opportunity," Mr. Deneault concluded.

According to an April 2022 report by Global Market Insights, the CBD market totaled $12.8 billion in 2021 and is expected to grow at a CAGR of 21.7% between 2022 and 2028. This expected growth is attributed to rising awareness of health benefits of CBD and its effectiveness in pain management and various other treatments. In addition, pet wellness is becoming a significant driver of CBD sales growth.

https://www.yahoo.com/now/black-bird-biotech-opens-grizzly-125500955.html

BBBT Black Bird Biotech Opens Grizzly Creek Naturals CBD Affiliate Sales Sign-up Portal Ahead of Sales Program Launch
Black Bird Biotech, Inc.
Tue, August 9, 2022 at 8:55 AM·3 min read
FLOWER MOUND, TX / ACCESSWIRE / August 9, 2022 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer and distributor of plant-based MiteXstreamTM biopesticide, announced the opening of a Sign-up Portal for its Affiliate Sales Program for its Grizzly Creek NaturalsTM CBD product line. Future Grizzly Creek NaturalsTM Affiliate Sales Reps can sign up at GrizzlyCreekAffiliates.com. The Company has scheduled the program launch for September 7, 2022.

"We ensure that our CBD products are of the highest quality and have been successful in maintaining a low-cost production capability, which has become extremely important in this period of significant inflation that has hit the supply chain especially hard," said Fabian Deneault, BBBT's President. "Our affiliate sales program is designed to minimize the impact of inflationary pressures on our end and, with a 20% sales commission structure, to maximize the reward for our Affiliates. As a guy that took on extra work to provide for his young family, I know that supplemental income from commissions that can offset the recent sudden increases in food and gas prices will be a welcomed opportunity," Mr. Deneault concluded.

According to an April 2022 report by Global Market Insights, the CBD market totaled $12.8 billion in 2021 and is expected to grow at a CAGR of 21.7% between 2022 and 2028. This expected growth is attributed to rising awareness of health benefits of CBD and its effectiveness in pain management and various other treatments. In addition, pet wellness is becoming a significant driver of CBD sales growth.

https://www.yahoo.com/now/black-bird-biotech-opens-grizzly-125500955.html

$BBBT Black Bird Biotech Opens Grizzly Creek Naturals CBD Affiliate Sales Sign-up Portal Ahead of Sales Program Launch
Black Bird Biotech, Inc.
Tue, August 9, 2022 at 8:55 AM·3 min read
FLOWER MOUND, TX / ACCESSWIRE / August 9, 2022 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer and distributor of plant-based MiteXstreamTM biopesticide, announced the opening of a Sign-up Portal for its Affiliate Sales Program for its Grizzly Creek NaturalsTM CBD product line. Future Grizzly Creek NaturalsTM Affiliate Sales Reps can sign up at GrizzlyCreekAffiliates.com. The Company has scheduled the program launch for September 7, 2022.

"We ensure that our CBD products are of the highest quality and have been successful in maintaining a low-cost production capability, which has become extremely important in this period of significant inflation that has hit the supply chain especially hard," said Fabian Deneault, BBBT's President. "Our affiliate sales program is designed to minimize the impact of inflationary pressures on our end and, with a 20% sales commission structure, to maximize the reward for our Affiliates. As a guy that took on extra work to provide for his young family, I know that supplemental income from commissions that can offset the recent sudden increases in food and gas prices will be a welcomed opportunity," Mr. Deneault concluded.

According to an April 2022 report by Global Market Insights, the CBD market totaled $12.8 billion in 2021 and is expected to grow at a CAGR of 21.7% between 2022 and 2028. This expected growth is attributed to rising awareness of health benefits of CBD and its effectiveness in pain management and various other treatments. In addition, pet wellness is becoming a significant driver of CBD sales growth.

https://www.yahoo.com/now/black-bird-biotech-opens-grizzly-125500955.html

$BBBT Black Bird Biotech Readies for Illinois State Fair and Du Quoin State Fair in America’s Heartland and Cannabis Conference 2022 in Las Vegas
Black Bird Biotech, Inc.
Tue, August 2, 2022 at 9:15 AM·

Black Bird Biotech, Inc.
Tue, August 2, 2022 at 9:15 AM·3 min read
FLOWER MOUND, TX / ACCESSWIRE / August 2, 2022 / Black Bird Biotech, Inc. (OTC:BBBT), manufacturer and distributor of plant-based MiteXstreamTM biopesticide, announced that its marketing team will be exhibiting MiteXstreamTM at the Illinois State Fair in Springfield from August 11th to the 21st, the Du Quoin (Illinois) State Fair from August 26th to September 5th and Cannabis Conference 2022 in Las Vegas from August 23th to the 25th.

"Exhibiting at the State Fairs in Illinois will have us in front of over 100,000 farmers from all over the Midwest where, on top of the usual challenges, spider mites have been invasive in many locales this year," said Fabian Deneault, BBBT's President and developer of MiteXstreamTM. "Spire+ has been leading the effort necessary to achieving distribution within the Ag Industry, in addition to implementing its online strategies, including our MiteXstream Amazon® Store. Likewise, Bill LoBell, our Sales V.P., will be heading our team at Cannabis Conference 2022, an exciting post-pandemic opportunity to expose large cannabis operators to the value proposition of MiteXstreamTM."

The company will be posting regular updates from these events on Twitter at @BBBT_Corporate.
Yahoo

ACCESSWIRE
Black Bird Biotech Readies for Illinois State Fair and Du Quoin State Fair in America’s Heartland and Cannabis Conference 2022 in Las Vegas
Black Bird Biotech, Inc.
Tue, August 2, 2022 at 9:15 AM·3 min read
FLOWER MOUND, TX / ACCESSWIRE / August 2, 2022 / Black Bird Biotech, Inc. (OTC:BBBT), manufacturer and distributor of plant-based MiteXstreamTM biopesticide, announced that its marketing team will be exhibiting MiteXstreamTM at the Illinois State Fair in Springfield from August 11th to the 21st, the Du Quoin (Illinois) State Fair from August 26th to September 5th and Cannabis Conference 2022 in Las Vegas from August 23th to the 25th.

"Exhibiting at the State Fairs in Illinois will have us in front of over 100,000 farmers from all over the Midwest where, on top of the usual challenges, spider mites have been invasive in many locales this year," said Fabian Deneault, BBBT's President and developer of MiteXstreamTM. "Spire+ has been leading the effort necessary to achieving distribution within the Ag Industry, in addition to implementing its online strategies, including our MiteXstream Amazon® Store. Likewise, Bill LoBell, our Sales V.P., will be heading our team at Cannabis Conference 2022, an exciting post-pandemic opportunity to expose large cannabis operators to the value proposition of MiteXstreamTM."

The company will be posting regular updates from these events on Twitter at @BBBT_Corporate.

For other news and updates, shareholders, prospective investors and prospective business partners are encouraged to follow @BBBT_Corporate on Twitter and @BlackBirdBiotech on Instagram. Also visit BBBT's corporate website, BlackBirdBiotech.com, for additional information about the company.

About BBBT

Black Bird Biotech is positioned to exploit market segments with powerful, re-imagined biotech products. Its EPA-registered biopesticide, MiteXstreamTM, eradicates mites and similar pests, including spider mites (a lethal pest in cannabis, grapes, hops, coffee, strawberries and many other agricultural crops), and eliminates molds and mildews. MiteXstreamTM is a pesticide, but it is not a poison - it's a pesticide re-imagined. The MiteXstreamTM Edge: use through the day of harvest without concern for residual "pesticide" violations, including as it pertains to state cannabis testing. MiteXstreamTM is the foundational element of the company that carries vast potential worldwide as a highly effective, safe and extremely cost-effective replacement for many traditional "poisonous" pesticides.

Forward Looking Statements:

This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

What's it gonna take for this to start running ya think?
Share structure is great.
Gotta get the fires burning

Yesss sir.! Things keep moving forward.

Black Bird Biotech to Launch National Direct Sales and Secure Distribution Channels for its Grizzly Creek Naturals(TM) CBD Product Line
Black Bird Biotech, Inc.
Tue, July 26, 2022 at 9:10 AM·3 min read
In this article:
FLOWER MOUND, TX / ACCESSWIRE / July 26, 2022 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer and distributor of plant-based MiteXstreamTM biopesticide, announced that it will launch an affiliate sales program for its Grizzly Creek NaturalsTM CBD product line in early August 2022. The Company also announced that it is in negotiations to secure distribution for its CBD product line with national reach, with the expectation that a final agreement will also be reached in early August 2022.

"During the past few months, we have experienced an uptick in overall interest in our CBD products, which has now manifested itself in direct sales and distribution channel opportunities," said Fabian Deneault, BBBT's President. "Our CBD products, nearly all of which are manufactured by us using as few ingredients as possible, have always been favorably compared to competing products and we expect that they will find high success in our national distribution and direct sales channels."

According to an April 2022 report by Global Market Insights, the CBD market totaled $12.8 billion in 2021 and is expected to grow at a CAGR of 21.7% between 2022 and 2028. This expected growth is attributed to rising awareness of health benefits of CBD and its effectiveness in pain management and various other treatments. In addition, pet wellness is becoming a significant driver of CBD sales growth.

For news and updates, shareholders, prospective investors and prospective business partners are encouraged to follow @BBBT_Corporate on Twitter and @BlackBirdBiotech on Instagram. Also visit BBBT's corporate website, BlackBirdBiotech.com, for additional information about the company.

Black Bird Biotech, Inc., Tuesday, July 26, 2022, Press release picture
Black Bird Biotech, Inc., Tuesday, July 26, 2022, Press release picture
About BBBT

Black Bird Biotech is positioned to exploit market segments with powerful, re-imagined biotech products. Its EPA-registered biopesticide, MiteXstreamTM, eradicates mites and similar pests, including spider mites (a lethal pest in cannabis, grapes, hops, coffee, strawberries and many other agricultural crops), and eliminates molds and mildews. MiteXstreamTM is a pesticide, but it is not a poison - it's a pesticide re-imagined. The MiteXstreamTM Edge: use through the day of harvest without concern for residual "pesticide" violations, including as it pertains to state cannabis testing. MiteXstreamTM is the foundational element of the company that carries vast potential worldwide as a highly effective, safe and extremely cost-effective replacement for many traditional "poisonous" pesticides.

Forward Looking Statements:

This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Contact:

Eric Newlan
Vice President
833-223-4204
eric@newlanpllc.com
BlackBirdBiotech.com

Nice.!
And Good morning to you sir...!

$BBBT Got me back in the trenches after being off here for the past 5 years.
Andddddd it all starts again bro...
Couldn't resist this one

Whoever sold me 37,000 shares then sold me 65,000 more today.
I appreciate it.!.!.!

$BBBT.... Black Bird Biotech Inc (OTCMKTS:BBBT) Stock Moves Up After Issuing Key Updates
Posted By Mavis Babcock on July 20, 2022

Black Bird Biotech Inc (OTCMKTS:BBBT) is looking to make a foray into several market segments, via potent, re-imaged biotech products. Its EPA-registered biopesticide, MiteXstream, destroys mites and similar pests while eliminating mold and mildew as well.

Trading Data
On Tuesday, BBBT stock increased by 18.18% to $0.0065 with more than 310K shares, compared to its average volume of 1.2 million shares. The stock moved within a range of $0.0063 – 0.0066 after opening trading at $0.0065.


Black Bird Biotech Provides Update As Global Concern Over Lasting Effects of Widely-Used Traditional Pesticides on Humans, Wildlife Continues to Rise
Black Bird Biotech, Inc. confirmed the registration of MiteXstream in 47 states and D.C., on July 19, 2002. Near-term clearance is expected in Indiana and Florida too, while initial registration in California is set to commence in the first half of 2023. It has recently started the process for obtaining registration in Peru, and further international registration of MiteXstream internationally, including in Canada and the EU, is scheduled to begin during the current quarter.

Fabian Deneault, President of Black Bird Biotech, Inc. has said that reports are received daily about the lingering toxicity of pesticides that have been used all over the world. It is time for an urgent call to action, to handle the pests in a better way. MiteXstream is the solution that is the need of the hour. It is sort of a “pesticide re-imagined” – gentle enough to be totally non-toxic to bees while delivering high efficacy at low cost.

Key Quote
“It seems that every day there is a new report published that highlights the lingering toxicity of the pesticides that have been used all over the world, with these reports being accompanied with an urgent call to action for a better way to handle the pests. MiteXstreamTM answers that call, as a ‘pesticide re-imagined,’ it is ‘gentle’ enough to be completely non-toxic to bees, yet delivers high efficacy at low cost,” said Fabian Deneault, BBBT’s President. The reports on bees are available here and here.

Black Bird Biotech Announces Second Successful MiteXstream Honey Bee Test Results: Not Toxic to Honey Bees When Ingested
In early June of this year, Black Bird Biotech had confirmed that after running additional lab tests, MiteXstream is 100% non-toxic to honey bees, after they ingest the biopesticide. The results were announced after it was determined that the product tested as non-toxic to honey bees when contacted topically.

The high efficacy and cost-effectiveness will grant the company leverage as they look forward to expanding sales channels. The findings certainly demonstrate the game-changing capabilities that MiteXstream brings to the many facets of the agricultural industry.

Being the world’s most important group of pollinators, bees are a crucial part of agricultural production and natural ecosystem function. Black Bird Biotech is proud of its MiteXstream product which is both an effective means of controlling pests, including spider mites (a lethal pest in cannabis, grapes, hops, coffee, strawberries, and many other agricultural crops), molds and other harmful agricultural issues, without being harmful to honey bees.

As per Fortune Business Insights, the Biopesticides Market is estimated to be worth $10.63 billion by 2027, with a CAGR of 13.1%, a growth that will be boosted by rising research activities to develop new microbial products.

Technical Data
BBBT stock is trading below the 20-Day and 50-Day Moving averages of $0.0068 and $0.0078 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.0137. The company has a total market capitalization of $1.98 million. The stock is down 26% over the past month.

$BBBT... Black Bird Biotech Provides Update As Global Concern Over Lasting Effects of Widely-Used Traditional Pesticides on Humans, Wildlife Continues to Rise
Tue, July 19, 2022 at 9:00 AM·4 min read
FLOWER MOUND, TX / ACCESSWIRE / July 19, 2022 /Black Bird Biotech, Inc.(OTC PINK:BBBT), manufacturer and distributor of plant-based MiteXstreamTM biopesticide, confirmed that MiteXstreamTM is now registered in 47 states and D.C., with near-term clearance expected in Florida and Indiana. Initial registration in California is targeted for the first half of 2023. The company also confirmed that it recently began the process for obtaining registration in Peru, and that further international registration of MiteXstreamTM internationally, including in Canada and the EU, is scheduled to begin during the current quarter.

"It seems that every day there is a new report published that highlights the lingering toxicity of the pesticides that have been used all over the world, with these reports being accompanied with an urgent call to action for a better way to handle the pests. MiteXstreamTM answers that call, as a ‘pesticide re-imagined,' it is ‘gentle' enough to be completely non-toxic to bees, yet delivers high efficacy at low cost," said Fabian Deneault, BBBT's President. The reports on bees are available here and here.

According to Fortune Business Insights™, the Biopesticides Market is forecast to be worth $10.63 Billion for 2027, with a CAGR at 13.1%, which growth will be boosted by rising research activities to develop new microbial products.

Scroll to continue with contentAd
Moment
A USDA report stated, "As the world's most important group of pollinators, bees are a crucial part of agricultural production and natural ecosystem function."

Black Bird Biotech is proud to offer the MiteXstreamTM product that is both an effective means of controlling pests, including spider mites, molds and other harmful agricultural issues while testing as not-toxic to honey bees.

MiteXstreamTM is currently available at MiteXstream.com and in the MiteXstream Amazon® Store.

For news and updates, shareholders, prospective investors and prospective business partners are encouraged to follow @BBBT_Corporate on Twitter and @BlackBirdBiotech on Instagram. Also visit BBBT's corporate website, BlackBirdBiotech.com, for additional information about the company.

Black Bird Biotech, Inc., Tuesday, July 19, 2022, Press release picture
Black Bird Biotech, Inc., Tuesday, July 19, 2022, Press release picture
About BBBT

Black Bird Biotech is positioned to exploit market segments with powerful, re-imagined biotech products. Its EPA-registered biopesticide, MiteXstreamTM, eradicates mites and similar pests, including spider mites (a lethal pest in cannabis, grapes, hops, coffee, strawberries and many other agricultural crops), and eliminates molds and mildews. MiteXstreamTM is a pesticide, but it is not a poison - it's a pesticide re-imagined. The MiteXstreamTM Edge: use through the day of harvest without concern for residual "pesticide" violations, including as it pertains to state cannabis testing. MiteXstreamTM is the foundational element of the company that carries vast potential worldwide as a highly effective, safe and extremely cost-effective replacement for many traditional "poisonous" pesticides.

Forward Looking Statements:

This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Contact:

Eric Newlan
Vice President
833-223-4204
eric@newlanpllc.com
BlackBirdBiotech.com

SOURCE: Black Bird Biotech, Inc